Chlorambucil treatment of frequently relapsing nephrotic syndrome - PubMed (original) (raw)
Clinical Trial
Chlorambucil treatment of frequently relapsing nephrotic syndrome
W E Grupe et al. N Engl J Med. 1976.
Abstract
Chlorambucil, in combination with prednisone, was compared with prednisone alone in a randomized controlled trial in 21 children with either steroid-dependent or frequently relapsing nephrotic syndrome to assess its effect on the duration of remission and the rate of relapse. All control patients treated with prednisone alone continued to relapse at the same rate, with all patients experiencing a return of proteinuria by seven months. Conversely, those who received the same prednisone therapy along with chlorambucil for six to 12 weeks remained in complete remission, without further medication, during 12 to 34 months of follow-up observation. Complications were minimal. Immediate side effects commonly reported with cyclophosphamide were not seen with chlorambucil. Comparison with published reports also suggests that remission induced by chlorambucil is more stable than that after cyclophosphamide. Chlorambucil appears to be of value in the frequently relapsing nephrotic patient, adding an effect that is unattainable with prednisone alone.
Similar articles
- Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood.
Williams SA, Makker SP, Ingelfinger JR, Grupe WE. Williams SA, et al. N Engl J Med. 1980 Apr 24;302(17):929-33. doi: 10.1056/NEJM198004243021701. N Engl J Med. 1980. PMID: 6987521 Clinical Trial. - Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA, Levtchenko EN, Wetzels JF. Kyrieleis HA, et al. Am J Kidney Dis. 2007 May;49(5):592-7. doi: 10.1053/j.ajkd.2007.02.270. Am J Kidney Dis. 2007. PMID: 17472840 - Conventional therapy for idiopathic nephrotic syndrome in children.
Brodehl J. Brodehl J. Clin Nephrol. 1991;35 Suppl 1:S8-15. Clin Nephrol. 1991. PMID: 1860269 Review. - [Treatment of nephrotic syndrome in children (author's transl)].
Schärer K. Schärer K. Monatsschr Kinderheilkd. 1980 Nov;128(11):685-8. Monatsschr Kinderheilkd. 1980. PMID: 6110172 Review. German.
Cited by
- Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG, Hahn D, Liu ID, Willis NS, Craig JC, Hodson EM. Larkins NG, et al. Cochrane Database Syst Rev. 2024 Nov 8;11(11):CD002290. doi: 10.1002/14651858.CD002290.pub6. Cochrane Database Syst Rev. 2024. PMID: 39513526 Review. - Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM. Larkins NG, et al. Cochrane Database Syst Rev. 2020 Apr 16;4(4):CD002290. doi: 10.1002/14651858.CD002290.pub5. Cochrane Database Syst Rev. 2020. PMID: 32297308 Free PMC article. Updated. - Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.
Tan L, Li S, Yang H, Zou Q, Wan J, Li Q. Tan L, et al. Medicine (Baltimore). 2019 May;98(22):e15927. doi: 10.1097/MD.0000000000015927. Medicine (Baltimore). 2019. PMID: 31145359 Free PMC article. - History of Nephrotic Syndrome and Evolution of its Treatment.
Pal A, Kaskel F. Pal A, et al. Front Pediatr. 2016 May 30;4:56. doi: 10.3389/fped.2016.00056. eCollection 2016. Front Pediatr. 2016. PMID: 27303658 Free PMC article. Review. - Corticosteroid therapy for nephrotic syndrome in children.
Hahn D, Hodson EM, Willis NS, Craig JC. Hahn D, et al. Cochrane Database Syst Rev. 2015 Mar 18;2015(3):CD001533. doi: 10.1002/14651858.CD001533.pub5. Cochrane Database Syst Rev. 2015. PMID: 25785660 Free PMC article. Updated. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources